Favipiravir is an antiviral used to manage influenza, and that has the potential to target other viral infections. Discovered by Toyama Chemical Co., Ltd. in Japan, favipiravir is a modified pyrazine analog that was initially approved for therapeutic use in resistant cases of influenza.